Von Hippel-Lindau gene expression on the human fallopian tube epithelium during the menstrual cycle

Lu,Yan-Yan; Zhu,Wei-Jie; Xie,Bao-Guo

doi:10.3892/mmr.2015.3237

Von Hippel-Lindau gene expression on the human fallopian tube epithelium during the menstrual cycle

Authors:
- Yan-Yan Lu
- Wei-Jie Zhu
- Bao-Guo Xie
View Affiliations

Affiliations: Department of Developmental and Regenerative Biology, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong 510632, P.R. China
Published online on: January 22, 2015 https://doi.org/10.3892/mmr.2015.3237
Pages: 4414-4418

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The Von Hippel-Lindau gene (VHL) is a tumor suppressor gene, which is widely expressed in kidney, lung, breast, ovary, and cervix. VHL gene mutations can induce VHL disease and tumorigenesis. However, whether this gene is expressed in the human fallopian tube has not been evaluated. The objectives of this study were to investigate whether the VHL gene is expressed in human fallopian tube, and to investigate its expression changes during the menstrual cycle. Twenty‑seven patients undergoing abdominal hysterectomy with adnexectomy for benign uterine disease were enrolled in the study. Human fallopian tubes were divided into proliferative stage (n=14) and secretory stage (n=13) according to the stage of the menstrual cycle they were isolated from. The expression of the VHL gene and protein was studied by reverse transcription-polymerase chain reaction (RT-PCR), western blotting and immunohistochemistry, respectively. The results revealed positive expression of the VHL protein in the cytoplasm of ciliated cells of the human fallopian tube. The mRNA and protein expression of VHL in the fallopian tubes was higher in the proliferative compared to the secretory phase of the menstrual cycle, but this difference was not significant (P>0.05). Overall, this study presents data on the VHL mRNA and protein expression in the human fallopian tube, which may be relevant to the process of differentiation of ciliated and secretory cells.

View Figures

View References

1	Croxatto HB: Physiology of gamete and embryo transport through the fallopian tube. Reprod Biomed Online. 4:160–169. 2002. View Article : Google Scholar : PubMed/NCBI
2	Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317–1320. 1993. View Article : Google Scholar : PubMed/NCBI
3	Kamada M, Suzuki K, Kato Y, Okuda H and Shuin T: von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility. Cancer Res. 61:4184–4189. 2001.PubMed/NCBI
4	Lu N, Hui H, Yang H, Zhao K, Chen Y, You QD and Guo QL: Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway. Eur J Pharm Sci. 49:220–226. 2013. View Article : Google Scholar : PubMed/NCBI
5	Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V and Kaelin WG: Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2:423–427. 2000. View Article : Google Scholar : PubMed/NCBI
6	Zhou MI, Wang H, Foy RL, Ross JJ and Cohen HT: Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. Cancer Res. 64:1278–1286. 2004. View Article : Google Scholar : PubMed/NCBI
7	Schraml P, Struckmann K, Hatz F, Sonnet S, Kully C, Gasser T, Sauter G, Mihatsch MJ and Moch H: VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol. 196:186–193. 2002. View Article : Google Scholar : PubMed/NCBI
8	Shuin T, Yamasaki I, Tamura K, Okuda H, Furihata M and Ashida S: Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol. 36:337–343. 2006. View Article : Google Scholar : PubMed/NCBI
9	Rajakumar A, Doty K, Daftary A, Markovic N and Conrad KP: Expression of von Hippel Lindau (pVHL) protein in placentae from normal pregnant women and women with preeclampsia. Placenta. 27:411–421. 2006. View Article : Google Scholar
10	Noyes RW, Hertig AT and Rock J: Dating the endometrial biopsy. Am J Obstet Gynecol. 122:262–263. 1975.PubMed/NCBI
11	Richards FM, Schofield PN, Fleming S and Maher ER: Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Hum Mol Genet. 5:639–644. 1996. View Article : Google Scholar : PubMed/NCBI
12	Tang N, Mack F, Haase VH, Simon MC and Johnson RS: pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol. 26:2519–2530. 2006. View Article : Google Scholar : PubMed/NCBI
13	Davidowitz EJ, Schoenfeld AR and Burk RD: VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling. Mol Cell Biol. 21:865–874. 2001. View Article : Google Scholar : PubMed/NCBI
14	Schermer B, Ghenoiu C, Bartram M, Müller RU, Kotsis F, Höhne M, Kühn W, Rapka M, Nitschke R, Zentgraf H, et al: The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth. J Cell Biol. 175:547–554. 2006. View Article : Google Scholar : PubMed/NCBI
15	Lyons R, Saridogan E and Djahanbakhch O: The reproductive significance of human Fallopian tube cilia. Hum Reprod Update. 12:363–372. 2006. View Article : Google Scholar : PubMed/NCBI
16	Crow J, Amso NN, Lewin J and Shaw RW: Morphology and ultrastructure of fallopian tube epithelium at different stages of the menstrual cycle and menopause. Hum Reprod. 9:2224–2233. 1994.PubMed/NCBI
17	Comer MT, Leese H and Southgate J: Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium. Hum Reprod. 13:3114–3120. 1998. View Article : Google Scholar : PubMed/NCBI
18	Esteban MA, Harten SK, Tran MG and Maxwell PH: Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J Am Soc Nephrol. 17:1801–1806. 2006. View Article : Google Scholar : PubMed/NCBI
19	Lutz MS and Burk RD: Primary cilium formation requires von hippel-lindau gene function in renal-derived cells. Cancer Res. 66:6903–6907. 2006. View Article : Google Scholar : PubMed/NCBI
20	Makrigiannakis A, Karamouti M, Petsas G, Makris N, Nikas G and Antsaklis A: The expression of receptivity markers in the fallopian tube epithelium. Histochem Cell Biol. 132:159–167. 2009. View Article : Google Scholar : PubMed/NCBI
21	Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr and Iliopoulos O: The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell. 1:959–968. 1998. View Article : Google Scholar : PubMed/NCBI
22	Zhou Q, Pardo A, Königshoff M, Eickelberg O, Budinger GR, Thavarajah K, Gottardi CJ, Jones J, Varga J and Selman M: Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis. FASEB J. 25:3032–3044. 2011. View Article : Google Scholar : PubMed/NCBI
23	Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM and Oldfield EH: von Hippel-Lindau disease. Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
24	Sülz L, Valenzuela JP, Salvatierra AM, Ortiz ME and Croxatto HB: The expression of alpha (v) and beta3 integrin subunits in the normal human Fallopian tube epithelium suggests the occurrence of a tubal implantation window. Hum Reprod. 13:2916–2920. 1998. View Article : Google Scholar
25	Guo W and Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 5:816–826. 2004. View Article : Google Scholar : PubMed/NCBI
26	Ji Q and Burk RD: Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation. Biochem Cell Biol. 86:227–234. 2008. View Article : Google Scholar : PubMed/NCBI
27	Esteban-Barragán MA, Ávila P, Álvarez-Tejado M, Gutiérrez MD, García-Pardo Á, Sánchez-Madrid F and Landázuri MO: Role of the von Hippel-Lindau tumor suppressor gene in the formation of β1-integrin fibrillar adhesions. Cancer Res. 62:2929–2936. 2002.
28	Mastroianni L Jr: The fallopian tube and reproductive health. J Pediatr Adolesc Gynecol. 12:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
29	Wanggren K, Lalitkumar P, Stavreus-Evers A, Stabi B and Gemzell-Danielsson K: Prostaglandin E2 and F2alpha receptors in the human Fallopian tube before and after mifepristone treatment. Mol Hum Reprod. 12:577–585. 2006. View Article : Google Scholar : PubMed/NCBI
30	Semenza GL: Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE. 2007:pp. cm82007, View Article : Google Scholar : PubMed/NCBI
31	Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:271–275. 1999. View Article : Google Scholar : PubMed/NCBI